These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 19476508)

  • 1. Assessment of haemophilia treatment practice pattern in Japan.
    Ono O; Suzuki Y; Yosikawa K; Wada I; Doi Y; Takano M; Wada Y; Fukushima K;
    Haemophilia; 2009 Sep; 15(5):1032-8. PubMed ID: 19476508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current situation of regular replacement therapy (prophylaxis) for haemophilia in Japan.
    Taki M; Shirahata A
    Haemophilia; 2009 Jan; 15(1):78-82. PubMed ID: 18700841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment trends for haemophilia A and haemophilia B in the United States: results from the 2010 practice patterns survey.
    Zappa S; McDaniel M; Marandola J; Allen G
    Haemophilia; 2012 May; 18(3):e140-53. PubMed ID: 22533455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practice patterns in haemophilia A therapy -- global progress towards optimal care.
    Geraghty S; Dunkley T; Harrington C; Lindvall K; Maahs J; Sek J
    Haemophilia; 2006 Jan; 12(1):75-81. PubMed ID: 16409179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of prophylaxis in 2663 children and adults with haemophilia: results of the 2006 Canadian national haemophilia prophylaxis survey.
    Biss TT; Chan AK; Blanchette VS; Iwenofu LN; McLimont M; Carcao MD; ;
    Haemophilia; 2008 Sep; 14(5):923-30. PubMed ID: 18637844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compliance with treatment and understanding of own disease in patients with severe and moderate haemophilia.
    Lindvall K; Colstrup L; Wollter IM; Klemenz G; Loogna K; Grönhaug S; Thykjaer H
    Haemophilia; 2006 Jan; 12(1):47-51. PubMed ID: 16409174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor VIII prophylaxis for adult patients with severe haemophilia A: results of a US survey of attitudes and practices.
    Walsh CE; Valentino LA
    Haemophilia; 2009 Sep; 15(5):1014-21. PubMed ID: 19493018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Haemophilia A, B or von Willebrand disease type 3. Census of patients in the eastern part of Germany].
    Scholz U; Syrbe G; Koscielny J; Klamroth R;
    Hamostaseologie; 2008; 28(3):150-4. PubMed ID: 18521493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current prescription of prophylactic factor infusions and perceived adherence for children and adolescents with haemophilia: a survey of haemophilia healthcare professionals in the United States.
    Thornburg CD; Carpenter S; Zappa S; Munn J; Leissinger C
    Haemophilia; 2012 Jul; 18(4):568-74. PubMed ID: 22335526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing factor prophylaxis for the haemophilia population: where do we stand?
    Blanchette VS; Manco-Johnson M; Santagostino E; Ljung R
    Haemophilia; 2004 Oct; 10 Suppl 4():97-104. PubMed ID: 15479380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Joint outcomes in patients with haemophilia: the importance of adherence to preventive regimens.
    Berntorp E
    Haemophilia; 2009 Nov; 15(6):1219-27. PubMed ID: 19659939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The benefits of prophylactic treatment with APCC in patients with haemophilia and high-titre inhibitors: a retrospective case series.
    Valentino LA
    Haemophilia; 2009 May; 15(3):733-42. PubMed ID: 19298380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylaxis for severe haemophilia: clinical challenges in the absence as well as in the presence of inhibitors.
    Fischer K; Valentino L; Ljung R; Blanchette V
    Haemophilia; 2008 Jul; 14 Suppl 3():196-201. PubMed ID: 18510542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The challenge arising from the cost of haemophilia care: an audit of haemophilia treatment at Auckland Hospital.
    Harper P; Brasser M; Moore L; Teague L; Pitcher L; Ockelford P
    N Z Med J; 2003 Aug; 116(1180):U561. PubMed ID: 14581983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An analysis of factors affecting the incidence of inhibitor formation in patients with congenital haemophilia in Japan.
    Shirahata A; Fukutake K; Higasa S; Mimaya J; Oka T; Shima M; Takamatsu J; Taki M; Taneichi M; Yoshioka A;
    Haemophilia; 2011 Sep; 17(5):771-6. PubMed ID: 21682824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How well does the Canadian Haemophilia Outcomes-Kids' Life Assessment Tool (CHO-KLAT) measure the quality of life of boys with haemophilia?
    Young NL; Bradley CS; Wakefield CD; Barnard D; Blanchette VS; McCusker PJ
    Pediatr Blood Cancer; 2006 Sep; 47(3):305-11. PubMed ID: 16206209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of the Haemophilia Joint Health Score in study of episodically treated boys with severe haemophilia A and B in Lithuania.
    Saulyte Trakymiene S; Ingerslev J; Rageliene L
    Haemophilia; 2010 May; 16(3):479-86. PubMed ID: 20070384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changing pattern of care of boys with haemophilia in western European centres.
    Chambost H; Ljung R;
    Haemophilia; 2005 Mar; 11(2):92-9. PubMed ID: 15810909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemophilia in Spain.
    Aznar JA; Lucía F; Abad-Franch L; Jiménez-Yuste V; Pérez R; Batlle J; Balda I; Parra R; Cortina VR
    Haemophilia; 2009 May; 15(3):665-75. PubMed ID: 19432921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemophilia in Poland.
    Windyga J; Lopaciuk S; Stefanska E; Juszynski A; Wozniak D; Strzelecki O; Szczepanik AB
    Haemophilia; 2006 Jan; 12(1):52-7. PubMed ID: 16409175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.